dr. garon on potential for immunotherapy in egfr nsclc
Published 5 years ago • 150 plays • Length 0:56Download video MP4
Download video MP3
Similar videos
-
1:07
dr. garassino on immunotherapy in egfr-mutated lung cancer
-
0:54
dr. garon on immunotherapy for patients with nsclc
-
2:30
dr. garon on concerns for immunotherapy combinations in lung cancer
-
1:14
dr. garon discusses immunotherapy as salvage treatment for advanced lung cancer
-
2:13
dr garon on considerations for perioperative immunotherapy use in lung cancer
-
1:22
dr. garon on future of immunotherapy in nsclc
-
1:04
dr. garon on immunotherapy in stage iii unresectable nsclc
-
1:25
dr. garon on incorporating immunotherapies into lung cancer treatment
-
1:59
dr. garon on sequencing of agents for advanced lung cancer
-
1:41
impower150 data for immunotherapy quadruplet in egfr-mutant lung cancer
-
3:22
treatment options: newly diagnosed egfr nsclc
-
4:25
do immune checkpoint inhibitors work in egfr mutant lung cancer?
-
3:53
the potential for adjuvant immunotherapy for nsclc
-
1:56
dr. jahanzeb on eligibility criteria for immunotherapy trials in nsclc
-
1:52
dr. camidge on optimal therapy in egfr nsclc
-
1:57
dr. piotrowska on treatment for egfr-mutant nsclc
-
1:37
dr. konduri on treatment options for patients with egfr-mutant nsclc
-
0:35
dr. farago on the fda approval of pembrolizumab for lower pd-1 cutoff nsclc
-
1:00:44
practical application of recent clinical data for immunotherapy in nsclc